Home Newsfeeds Pot Decriminalization Bill Teed Up For Senate Introduction

Pot Decriminalization Bill Teed Up For Senate Introduction

-Bloomberg

byBenzinga Newsdesk

July 14, 2022

1 minute read

-Bloomberg

News

‘Netflix’s New Ad Tier Looks to Be Off To A Tepid Start’ – Variety

By Benzinga Newsdesk

December 22, 11:45 AM

https://variety.com/2022/digital/news/netflix-with-ads-subscriber-signup-research-data-1235468044/ Netflix, after years of insisting it wouldn’t dive into the advertising business, threw its hat into the ring last

NFLX

Emerald Expositions Q4 EPS $0.06 Up From $(0.24) YoY, Sales $93.60M Up From $41.10M YoY

By Benzinga Newsdesk

March 14, 6:27 AM

Emerald Expositions (NYSE:EEX) reported quarterly earnings of $0.06 per share. This is a 125 percent increase over losses of $(0.24) per share from the same period last year. The company reported $93.60 million in sales

EEX

Barclays Maintains Overweight on Medical Properties Trust, Lowers Price Target to $14

By Benzinga Newsdesk

February 27, 7:35 AM

Barclays analyst Steven Valiquette maintains Medical Properties Trust (NYSE:MPW) with a Overweight and lowers the price target from $17 to $14.

MPW

Wendy’s Q3 EPS $0.24 Beats $0.23 Estimate, Sales $532.57M Miss $539.41M Estimate

By Bill Haddad

November 9, 8:00 AM

Wendy's (NASDAQ:WEN) reported quarterly earnings of $0.24 per share which beat the analyst consensus estimate of $0.23 by 4.35 percent. This is a 26.32 percent increase over earnings of $0.19 per share from the same

WEN

Pot Decriminalization Bill Teed Up For Senate Introduction

Related Posts

‘Netflix’s New Ad Tier Looks to Be Off To A Tepid Start’ – Variety

Emerald Expositions Q4 EPS $0.06 Up From $(0.24) YoY, Sales $93.60M Up From $41.10M YoY

Barclays Maintains Overweight on Medical Properties Trust, Lowers Price Target to $14

Wendy’s Q3 EPS $0.24 Beats $0.23 Estimate, Sales $532.57M Miss $539.41M Estimate